Systemic curcumin administration mitigates neuropathic pain in a rat model of trigeminal neuralgia by suppressing TNF-α and pSTAT3 signaling
Molecular Pain · 2026
DOI: 10.1177/17448069261445281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pain, 2026. Verfasst von Dara Sari Arini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Health Science and Social Welfare, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan. Hauptthemen laut MEDLINE: Curcumin, STAT3 Transcription Factor, Trigeminal Neuralgia, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ministry of education, Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
Abstract (Originalsprache)
Trigeminal neuralgia (TN) is a debilitating neuropathic facial pain disorder characterized by sudden, severe paroxysmal pain that markedly impairs quality of life. Although current pharmacological treatments provide pain relief, their adverse effects highlight the need for safer alternative therapies. Curcumin, a natural polyphenol, exhibits anti-inflammatory and neuroprotective properties with minimal side effects. In this study, we examined the impact of intraperitoneal curcumin administration on the trigeminal ganglia in a TN rat model induced by unilateral infraorbital nerve constriction (IONC). Behavioral tests revealed that curcumin significantly reduced mechanical hypersensitivity compared with vehicle-treated controls. Immunohistochemical analysis showed decreased expression of glial fibrillary acidic protein (GFAP) and activating transcription factor 3 (ATF3), established markers of satellite glial cell (SGC) activation and neuronal stress in the trigeminal ganglia. Furthermore, curcumin administration reduced tumor necrosis factor-α (TNF-α) expression and modulated phosphorylated signal transducer and activator of transcription 3 (pSTAT3) activity. These findings suggest that curcumin alleviates neuropathic pain by suppressing glial activation and pSTAT3-related pro-inflammatory signaling. Curcumin may therefore represent a promising potential therapeutic candidate for TN, warranting further investigation into its clinical applicability and underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Health Science and Social Welfare, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
- Department of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
- Department of Preventive Dentistry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
ORCID-Profile: Dara Sari Arini, Lutfi Putra Perdana, Jaime Fabillar, Misaki Ichinomiya, Yoshizo Matsuka, Kosuke Kataoka
Förderung
- ministry of education
- Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan
Zitieren
APA
Arini, D. S., Perdana, L. P., Fabillar, J., Miyagi, M., Ikutame, D., Koike, K., Suma, S., Ichinomiya, M., Matsuka, Y., & Kataoka, K. (2026). Systemic curcumin administration mitigates neuropathic pain in a rat model of trigeminal neuralgia by suppressing TNF-α and pSTAT3 signaling. Molecular Pain. https://doi.org/10.1177/17448069261445281
Vancouver
Arini DS, Perdana LP, Fabillar J, Miyagi M, Ikutame D, Koike K, et al. Systemic curcumin administration mitigates neuropathic pain in a rat model of trigeminal neuralgia by suppressing TNF-α and pSTAT3 signaling. Molecular Pain. 2026. doi:10.1177/17448069261445281
BibTeX
@article{Arini2026,
author = {Arini, Dara Sari and Perdana, Lutfi Putra and Fabillar, Jaime and Miyagi, Mayu and Ikutame, Daisuke and Koike, Kazuyuki and Suma, Shino and Ichinomiya, Misaki and Matsuka, Yoshizo and Kataoka, Kosuke},
title = {Systemic curcumin administration mitigates neuropathic pain in a rat model of trigeminal neuralgia by suppressing TNF-α and pSTAT3 signaling},
journal = {Molecular Pain},
year = {2026},
doi = {10.1177/17448069261445281}
}
EUVIMED